Migraine, Arthritis Internal Analgesics Post Strong 1999 Sales Growth - IRI
This article was originally published in The Tan Sheet
Executive Summary
Internal analgesics for targeted indications, such as migraine and arthritis, posted strong sales growth in food, drug and mass channels in 1999, while the overall category experienced only a modest gain, according to year-end sales data provided by Chicago-based Information Resources, Inc.
You may also be interested in...
Generic Nicotine Replacement Products Start To Smoke In 2000
Private label OTC smoking cessation products thrived in 2000, their first full year on the food, drug and mass market, recording sales well over $100 mil. and capturing nearly a 20% dollar share, according to data from Information Resources, Inc. (Chicago).
Generic Nicotine Replacement Products Start To Smoke In 2000
Private label OTC smoking cessation products thrived in 2000, their first full year on the food, drug and mass market, recording sales well over $100 mil. and capturing nearly a 20% dollar share, according to data from Information Resources, Inc. (Chicago).
Generic Nicotine Replacement Products Start To Smoke In 2000
Private label OTC smoking cessation products thrived in 2000, their first full year on the food, drug and mass market, recording sales well over $100 mil. and capturing nearly a 20% dollar share, according to data from Information Resources, Inc. (Chicago).